Abstract:Abstract Background Ulcerative colitis (UC) is a common inflammatory bowel disease, during which cell necroptosis plays key roles in driving inflammation initiation and aggravation. Previous studies reported Receptor Interacting Protein Kinase 3 (RIP3)-mediated necroptosis in multiple diseases, and RIP3 protein in Paneth cells significantly enriched in the intestines of both humans and mice. Therefore, we hypothesized targeting RIP3 to inhibit necroptosis may depress UC. Methods We classified clinical UC samples according to the modified Truelove & Witts criterion. The expression of RIP3 was measured by western blot and immunohistochemistry. Cell proliferation and apoptosis were analyzed by MTT assay and flow cytometry. ROS production and the secretion of inflammatory cytokines were measured by DCFH-DA probe and ELISA assay. TLR4/MyD88/NF-κB signaling pathway was analyzed by western blot. We established experimental colitis model in RIP3 knockout and wild-type mice and disease activity index (DAI) score was calculated. The expression and distribution of tight junction protein were analyzed by immunofluorescence. The ratio of CD4 + Foxp3 + T cells in the spleen was detected by flow cytometry. Oxidative damage of mouse colon was assessed by detecting the levels of SOD, MDA and MPO. Data were analyzed by one-way ANOVA or student’s t test. Results The expression of RIP3 in human colon is positively associated with the severity of UC. RIP3 inhibitor GSK872 or RIP3 knockdown reverses the inhibitory effect of TNF-α on proliferation and the promoting effect of TNF-α on apoptosis and necrosis in human intestinal epithelial cells. In addition, RIP3 deficiency inhibits the secretion of inflammatory cytokines (IL-16, IL-17 and IFN-γ) and ROS production induced by TNF-α. In vivo, RIP3 inhibitor Nec-1 effectively improves DSS-induced colitis in mice. In mechanism, RIP3 depression could upregulate the proportion of CD4 + Foxp3 + immunosuppressive Treg cells in the spleen while suppressed TLR4/MyD88/NF-κB signaling pathway and ROS generation, and all these anti-inflammation factors together suppress the secretion of inflammatory cytokines and necroptosis of intestinal epithelial cells. Conclusions This study preliminarily explored the regulating mechanism of RIP3 on UC, and Nec-1 may be a promising drug to alleviate the inflammation and necroptosis of the colon in UC patients.

Macrophage Tim-3 maintains intestinal homeostasis in DSS-induced colitis by suppressing neutrophil necroptosis

Tim-3 Promotes Intestinal Homeostasis in DSS Colitis by Inhibiting M1 Polarization of Macrophages

T-cell Immunoglobulin and Mucin Domain Protein 3 Protects the Intestine from Ischaemia–reperfusion Injury by Regulating Macrophage Polarisation

Tim-3 Inhibits Macrophage Control of Listeria Monocytogenes by Inhibiting Nrf2

Tim-3 promotes homeostasis of ulcerative colitis by inhibiting M1 macrophage polarization (INC6P.308)

P-315 The Necroptosis Adaptor RIPK3 Induces Tissue Repair in Response to Intestinal Injury

RIP3 knockdown inhibits necroptosis of human intestinal epithelial cells via TLR4/MyD88/NF-κB signaling and ameliorates murine colitis

CCN3 aggravates intestinal inflammation in inflammatory colitis through regulating NLRP3 inflammasome in macrophages

Tim-3 in Regulating the Activity and Phenotype of Macrophage

Involvement of T Cell Ig Mucin-3 (Tim-3) in the Negative Regulation of Inflammatory Bowel Disease.

Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis.

T Cell Immunoglobulin and Mucin Domain Protein 3 Inhibits Glycolysis in RAW 264.7 Macrophages Through Hexokinase 2.

Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice

Inhibition of METTL3 in macrophages provides protection against intestinal inflammation

Specific deletion of Mettl3 in IECs triggers the development of spontaneous colitis and dysbiosis of T lymphocytes in mice

Negative Regulation Of Nod-Like Receptor Protein 3 Inflammasome Activation By T Cell Ig Mucin-3 Protects Against Peritonitis

CD1d1 Intrinsic Signaling in Macrophages Controls NLRP3 Inflammasome Expression During Inflammation.

MTDH Promotes Intestinal Inflammation by Positively Regulating TLR Signalling.

Intestinal Epithelial Cell-specific Knockout of METTL3 Aggravates Intestinal Inflammation in CLP Mice by Weakening the Intestinal Barrier

T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response

Dynamic role of macrophage CX3CR1 expression in inflammatory bowel disease